Windtree Therapeutics Secures $857,000 Convertible Note Financing for CommLoan Acquisition
Windtree Therapeutics Inc. has secured $857,000 through senior convertible promissory notes for its planned acquisition of CommLoan Inc. The notes, maturing in 2026, have a 10% annual interest rate. Proceeds will advance $450,000 to CommLoan and retain $150,000 for corporate purposes. The agreement includes prepayment provisions and a 4.99% beneficial ownership limit for the investor. This information was published by Windtree Therapeutics via the SEC's EDGAR system.
Windtree Therapeutics Inc. has entered into a new debt financing agreement, issuing senior convertible promissory notes with an aggregate principal amount of $857,142.86 to an institutional investor. The notes, maturing on November 26, 2026, bear interest at 10% per annum and were issued in connection with Windtree’s planned acquisition of CommLoan Inc. Proceeds from the notes will be used to advance $450,000 to CommLoan and retain $150,000 for general corporate purposes. The agreement includes mandatory prepayment provisions and a prepayment premium, as well as a beneficial ownership limitation of 4.99% for the investor. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Windtree Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-036665), on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
